Patents by Inventor Paul William Glue

Paul William Glue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONISTS IN THE TREATMENT OF DEMYELINATING DISORDERS
    Publication number: 20140271541
    Abstract: Disclosed are pharmaceutical combinations comprising at least one S1P receptor agonist, as well as a method for treating demyelinating diseases, e.g. multiple sclerosis or disorders associated therewith or Guillain-Barré syndrome, comprising co-administration, e.g. concomitantly or in sequence, of a therapeutically effective amount of a) an S1P receptor agonist, and b) at least one co-agent shown to have clinical activity against at least one symptom of a demyelinating disease.
    Type: Application
    Filed: March 18, 2014
    Publication date: September 18, 2014
    Applicant: NOVARTIS AG
    Inventors: Carolyn Ann Foster, Peter C. Hiestand, Paul William Glue
  • SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONISTS IN THE TREATMENT OF DEMYELINATING DISORDERS
    Publication number: 20120225031
    Abstract: Disclosed are pharmaceutical combinations comprising at least one S1P receptor agonist, as well as a method for treating demyelinating diseases, e.g. multiple sclerosis or disorders associated therewith or Guillain-Barré syndrome, comprising co-administration, e.g. concomitantly or in sequence, of a therapeutically effective amount of a) an S1P receptor agonist, and b) at least one co-agent shown to have clinical activity against at least one symptom of a demyelinating disease.
    Type: Application
    Filed: May 4, 2012
    Publication date: September 6, 2012
    Inventors: Carolyn Ann FOSTER, Peter C. HIESTAND, Paul William GLUE
  • Use of neurokinin antagonists in the treatment of urinary incontinence
    Patent number: 7776851
    Abstract: This invention relates to compounds of formula I, wherein the R1, R2, R3, R4, R5, R6 and R7 are as defined in the specification, and, in particular, their use as pharmaceuticals, for use in the treatment of urinary incontinence.
    Type: Grant
    Filed: October 26, 2004
    Date of Patent: August 17, 2010
    Assignee: Novartis AG
    Inventors: Paul William Glue, Kevin Hall McAllister, Eckhard Weber
  • SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONISTS IN THE TREATMENT OF DEMYELINATING DISORDERS
    Publication number: 20090324542
    Abstract: Disclosed are pharmaceutical combinations comprising at least one S1P receptor agonist, as well as a method for treating demyelinating diseases, e.g. multiple sclerosis or disorders associated therewith or Guillain-Barré syndrome, comprising co-administration, e.g. concomitantly or in sequence, of a therapeutically effective amount of a) an S1P receptor agonist, and b) at least one co-agent shown to have clinical activity against at least one symptom of a demyelinating disease.
    Type: Application
    Filed: July 30, 2009
    Publication date: December 31, 2009
    Inventors: Carolyn Ann Foster, Peter C. Hiestand, Paul William Glue